StockData
InflaRx N.V. logo

InflaRx N.V. (IFRX) income statement

IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.04−0.05 (-4.59%)

Close on Nov 20, 2026Market cap $75.18MP/E –Yield –

See a number that looks wrong?